Biotechnology Visual Media
Loading...
Loading...
Loading...
Dendreon Gets FDA Acceptance For Prostrate Cancer Drug Application - Update - RTT News
Dendreon Gets FDA Acceptance For Prostrate Cancer Drug Application - Update - RTT News
Dendreon Gets FDA Acceptance For Prostrate Cancer Drug Application - Update RTT News (RTTNews) - Friday, biotechnology company Dendreon Corp. (DNDN: News ) revealed that the US Food and Drug Administration or FDA has accepted its amended ... Dendreon's Provenge gets FDA review date Dendreon Receives FDA Acknowledgement of Complete Response |
Dendreon Gets FDA Acceptance For Prostrate Cancer Drug Application - Update - RTT News
US Drug Stocks Mixed; Inovio Up On Vaccine Study Results - Wall Street Journal
US Drug Stocks Mixed; Inovio Up On Vaccine Study Results - Wall Street Journal
US Drug Stocks Mixed; Inovio Up On Vaccine Study Results Wall Street Journal The NYSE Arca Pharmaceutical Index was up slightly at 302.70 while the NYSE Arca Biotechnology Index was down 2.85 at 867. Inovio reported that animal ... Inovio's Pre-clinincal Study Of Universal Flu Vaccines Reports Protective ... |
US Drug Stocks Mixed; Inovio Up On Vaccine Study Results - Wall Street Journal
Vical Added to NASDAQ Biotechnology Index - CNNMoney.com (press release)
Vical Added to NASDAQ Biotechnology Index - CNNMoney.com (press release)
Vical Added to NASDAQ Biotechnology Index CNNMoney.com (press release) 16, 2009 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will be added to the NASDAQ Biotechnology Index effective ... Spectrum Pharmaceuticals Added to NASDAQ Biotechnology Index Vical will be added to biotech index, shares rise Targacept will be added to NASDAQ biotech index |
Vical Added to NASDAQ Biotechnology Index - CNNMoney.com (press release)
Second license deal with Amgen to bring ImmunoGen another $35M - Mass High Tech
Second license deal with Amgen to bring ImmunoGen another $35M - Mass High Tech
Second license deal with Amgen to bring ImmunoGen another $35M Mass High Tech By Mass High Tech staff Waltham biotechnology firm ImmunoGen Inc. has announced a second license granted to Amgen Inc. for its maytansinoid Targeted ... ImmunoGen Nabs $1M From Amgen ImmunoGen announces second license agreement with Amgen ImmunoGen's Second License to Amgen (IMGN, AMGN) |
Second license deal with Amgen to bring ImmunoGen another $35M - Mass High Tech
Reportlinker Adds Biotechnology Reagents - A Global Market Perspective - PR Newswire (press release)
Reportlinker Adds Biotechnology Reagents - A Global Market Perspective - PR Newswire (press release)
 Ad-Hoc-News (Pressemitteilung) | Reportlinker Adds Biotechnology Reagents - A Global Market Perspective PR Newswire (press release) Reagents used in biotechnology are complex chemical compounds used in a range of biotech related areas including biochemistry, cell biology, ... New Report Just Published Probiotics - A Global Update of Market Trends ... Reportlinker global Reportlinker Adds Laboratory Chemical Reagents - A Global Market Review |
Reportlinker Adds Biotechnology Reagents - A Global Market Perspective - PR Newswire (press release)
Reflect Scientific Enters Cooperative Agreement With Resonon - CNNMoney.com (press release)
Reflect Scientific Enters Cooperative Agreement With Resonon - CNNMoney.com (press release)
Reflect Scientific Enters Cooperative Agreement With Resonon CNNMoney.com (press release) Resonon systems have been used for defense, biotechnology, agriculture, sorting, mining, and manufacturing. For more information visit www.resonon.com. ... |
Reflect Scientific Enters Cooperative Agreement With Resonon - CNNMoney.com (press release)
Microbes and motorcycles gain Legislature's attention - Wisconsin State Journal
Microbes and motorcycles gain Legislature's attention - Wisconsin State Journal
Microbes and motorcycles gain Legislature's attention Wisconsin State Journal Gary Hebl, D-Sun Prairie, said his bill pays homage to Wisconsin's cheese heritage while promoting its image as a biotechnology hot spot. ... |
Microbes and motorcycles gain Legislature's attention - Wisconsin State Journal
Kannapolis superintendent to retire - CharlotteObserver.com
Kannapolis superintendent to retire - CharlotteObserver.com
 CharlotteObserver.com | Kannapolis superintendent to retire CharlotteObserver.com She was a driving force behind construction of an $11 million Biotechnology Academy at the high school, which already offers such high-level courses as ... |
Kannapolis superintendent to retire - CharlotteObserver.com
Champions Biotechnology Enters into Licensing Agreement with Yale University ... - PR Newswire (press release)
Champions Biotechnology Enters into Licensing Agreement with Yale University ... - PR Newswire (press release)
Champions Biotechnology Enters into Licensing Agreement with Yale University ... PR Newswire (press release) Champions Biotechnology, Inc. is engaged in the development of advanced preclinical platforms and tumor specific data to enhance and accelerate the value of ... Champions Biotechnology announces new licensing agreement |
Champions Biotechnology Enters into Licensing Agreement with Yale University ... - PR Newswire (press release)
DBT allocates Rs 200 cr to set up National Stem Cell Institute in Karnataka - pharmabiz.com
DBT allocates Rs 200 cr to set up National Stem Cell Institute in Karnataka - pharmabiz.com
 Telegraph.co.uk | DBT allocates Rs 200 cr to set up National Stem Cell Institute in Karnataka pharmabiz.com The Department of Biotechnology (DBT) has chipped in Rs 200 crore to set up Stem Cell Institute in Karnataka. The project is coming up on a 20 acre plot at ... Company seeks to test stem cells for blindness Embryonic Stem Cells to Treat Eye Disease - ACTC Advanced Stem cells: the first human trial |
DBT allocates Rs 200 cr to set up National Stem Cell Institute in Karnataka - pharmabiz.com